News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
538,382 Results
Type
Article (59385)
Company Profile (292)
Press Release (478705)
Section
Business (146412)
Career Advice (1342)
Deals (23485)
Drug Delivery (58)
Drug Development (74117)
Employer Resources (105)
FDA (12476)
Job Trends (11434)
News (257540)
Policy (22759)
Tag
Academia (2797)
Alliances (40900)
Alzheimer's disease (1315)
Approvals (12399)
Artificial intelligence (103)
Bankruptcy (166)
Best Places to Work (9242)
Biotechnology (200)
Breast cancer (91)
Cancer (846)
Cardiovascular disease (79)
Career advice (1126)
Cell therapy (198)
Clinical research (57675)
Collaboration (306)
Compensation (111)
COVID-19 (2491)
Cystic fibrosis (79)
Data (808)
Diabetes (105)
Diagnostics (5281)
Earnings (52142)
Employer resources (94)
Events (77039)
Executive appointments (204)
FDA (12851)
Funding (261)
Gene therapy (153)
GLP-1 (508)
Government (3571)
Healthcare (14518)
Infectious disease (2568)
Inflammatory bowel disease (113)
Interviews (266)
IPO (11574)
Job creations (2516)
Job search strategy (985)
Layoffs (323)
Legal (3800)
Lung cancer (155)
Manufacturing (112)
Medical device (8704)
Medtech (8706)
Mergers & acquisitions (12006)
Metabolic disorders (284)
Neuroscience (1564)
NextGen Class of 2024 (4635)
Non-profit (4201)
Northern California (1030)
Obesity (151)
Opinion (159)
Parkinson's disease (74)
Patents (75)
People (42658)
Phase I (17754)
Phase II (25502)
Phase III (19056)
Pipeline (187)
Postmarket research (2487)
Preclinical (8341)
Press Release (67)
Radiopharmaceuticals (199)
Rare diseases (196)
Real estate (4369)
Regulatory (16474)
Research institute (2580)
Resumes & cover letters (190)
Southern California (891)
Startups (2953)
United States (9667)
Vaccines (552)
Weight loss (108)
Date
Last 7 days (686)
Last 30 days (2328)
Last 365 days (30876)
2024 (26096)
2023 (34415)
2022 (44958)
2021 (48361)
2020 (44903)
2019 (35969)
2018 (27229)
2017 (26477)
2016 (25948)
2015 (30619)
2014 (23589)
2013 (20185)
2012 (20497)
2011 (21037)
2010 (19811)
Location
Africa (683)
Arizona (93)
Asia (33009)
Australia (6164)
California (2301)
Canada (937)
China (194)
Colorado (85)
Connecticut (109)
Europe (77097)
Florida (329)
Georgia (76)
Illinois (241)
Indiana (140)
Maryland (410)
Massachusetts (1915)
Michigan (116)
Minnesota (166)
New Jersey (740)
New York (735)
North Carolina (612)
Northern California (1030)
Ohio (103)
Pennsylvania (587)
South America (797)
Southern California (891)
Texas (322)
Washington State (281)
538,382 Results for "infectious disease research institute idri".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Traverse Biotech Awarded Phase I SBIR Grant by the National Institute of Allergy and Infectious Diseases for Development of Innate Immune Stimulator
Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.
May 1, 2024
·
1 min read
BioForest
Pacific Northwest Research Institute Uncovers Hidden DNA Mechanisms of Rare Genetic Diseases
Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders.
June 21, 2024
·
3 min read
Infectious disease
J&J Discontinues Phase II Dengue Study as it Retreats from Infectious Disease
J&J has recently pulled back from the infectious diseases space, including winding down R&D activity in this area in August 2023.
October 7, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Genetown
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell.
March 7, 2024
·
4 min read
Press Releases
Feinstein Institutes Research Shows Cancer Drugs Could Help With Vascular Disease
November 1, 2024
·
2 min read
Bankruptcy
Gritstone Files for Bankruptcy in Effort to Save Clinical Research
Vaccine biotech Gritstone bio is filing for bankruptcy while securing a stalking horse bid from an unnamed party, which the company hopes will save its clinical research in cancer and infectious disease.
October 10, 2024
·
1 min read
·
Annalee Armstrong
Business
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationAims to Leverage Diversified Data to Accelerate and De-Risk Drug Discovery and Clinical Development
CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”) and the Laboratory of Human Genetics of Infectious Diseases (the “Lab”) at Institut Imagine today announced a strategic research collaboration to improve health outcomes for rare disease patients by accelerating and de-risking drug discovery and clinical development.
January 25, 2024
·
8 min read
Press Releases
Adnexus Biotechnologies Unveils Sutra(TM), a Game-Changing AI Platform for Drug Discovery and Infectious Disease Research
October 2, 2024
·
4 min read
BioCapital
ReAlta Life Sciences Announces New Research Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate RLS-0071 as a Medical Countermeasure for Acute Radiation Syndrome
ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”) today announces that the company will be utilizing the preclinical services program offered by the National Institute of Allergy and Infectious Diseases (NIAID) to evaluate RLS-0071 as a medical countermeasure for Acute Radiation Syndrome (ARS).
March 28, 2024
·
3 min read
1 of 53,839
Next